BE Study List of articles

2026.08.17

Drug,prescription,for,treatment,medication.,pharmaceutical,medicament,,cure,in,container

Early Consideration on Safety Measures for Bioequivalence Studies in Healthy Volunteers in Generic Drug Development in Japan

Introduction to Safety Considerations for Bioequivalence Studies According to the notification issued by the P […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
Phone:+81-3-6304-5570